Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 477-483

  Andoh, A ^a   Fujiyama, Y ^a   Sakumoto, H ^a   Uchihara, H ^a   Kimura, T ^a   Koyama, S ^a   Bamba, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Complement; In situ hybridization; Intestine

Indexed keywords

COMPLEMENT COMPONENT C3;

ARTICLE; COLON MUCOSA; COLORECTAL CANCER; COMPLEMENT ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INFLAMMATION; NUCLEIC ACID PROBE; PRIORITY JOURNAL;

ADENOMA; CACO-2 CELLS; CARCINOMA; COLON; COLORECTAL NEOPLASMS; COMPLEMENT ACTIVATION; COMPLEMENT C3C; COMPLEMENT FACTOR B; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; INTESTINAL MUCOSA; REFERENCE VALUES;

EID: 0031943358     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00496.x     Document Type: Article

References (27)

1. Morgan BP. The complement system. In: Morgan BP ed. Complement: clinical aspects and relevance to disease. London: Academic Press, 1990:1-35.
2. Colten HR, Strunk RC. Synthesis of complement components in liver and at extrahepatic sites. In: Whaley K, Loos M, Weiler JM, eds. Complement in health and disease. Dordrecht: Kluwer Academic Publishers, 1993:127-58.
3. Ahrenstedt O, Knutson B, Nilsson-Ekdahl K et al. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 1990; 322:1345-9.
4. Andoh A, Fujiyama Y, Bamba T et al. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993; 151:4239-47.
5. Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268:14116-24.
6. Andoh A, Fujiyama Y, Bamba T et al. Complement component C3 production and its cytokine regulation by gastrointestinal epithelial cells. In: Mestecky J, Russel MW, Jackson S et al., eds. Advances in mucosal immunology, part A. New York: Plenum, 1995: 211-5.
7. Andoh A, Fujiyama Y, Sumiyoshi K et al. Modulation of complement C3, C4, and factor B production in human intestinal epithelial cells: differential effects of TNF-α, IFN-γ, and IL-4. Pathophysiology 1995; 2:251-9.
8. Niehans GA, Cherwitz DL, Staley NA et al. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 1996; 149:129-42.
9. Andoh A, Fujiyama Y, Sumiyoshi K et al. Interleukin-4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology 1996; 111:911-8.
10. De Bruijn MHL, Fey G. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985; 82:708-12.
11. Horiuchi T, Kim S, Matsumoto M et al. Human complement factor B: cDNA cloning nucleotide sequencing, phenotype conversion by site-directed mutagenesis and expression. Mol Imuunol 1993; 30:1587-92.
12. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74:5463-7.
13. Halstensen TS, Mollnes TE, Brandtzaeg P. Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology 1989; 97:10-19.
14. Halstensen TS, Hvatum M, Scott H et al. Association of subepithelial deposition of activated complement and immunoglobulin G and M response to gluten in celiac disease. Gastroenterology 1992; 102:751-9.
15. Halstensen TS, Mollnes TE, Garred P et al. Epithelial deposition of immunoglobulin G1 and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990; 98:1264-71.
16. Mestecky J, McGhee JR. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 1987; 40:153-245.
17. Schneiderman RD, Lint TF, Knight KL. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotype. J Immunol 1990; 145:233-7.
18. Hiemstra PS, Rits M, Gorter A et al. Rat polymeric IgA binds C1q, but does not activate Cl. Mol Immunol 1990; 27:867-74.
19. Bogers WMJM, Stad RK, van ES et al. Immunoglobulin A: interaction with complement, phagocytic cells and endothelial cells. Complement Inflamm 1991; 8:347-58.
20. Zhang W, Lachmann PJ. Glycosylation of IgA is required for optimal activation of alternative pathway by immune complexes. Immunology 1994; 81:137-41.
21. Ahnen DJ, Kinoshita K, Nakane PK et al. Differential expression of carcinoembryonic antigen and secretory component during colonic epithelial cell differentiation and in colon carcinomas. Gastroenterology 1987; 93:1330-8.
22. Kato T, Owen RL. Structure and function of intestinal mucosal epithelium. In: Ogra PL, Mestecky J, Lamm ME et al. eds. Handbook of mucosal immunology. San Diego: Academic Press 1994: 11-26.
23. Sollid LM, Kvale D, Brandtzaeg P et al. Interferon-γ enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol 1987; 138:4303-6.
24. Kvale D, Lovhang D, Sollid LM et al. Tumor necrosis factor-α up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol 1988; 140:3086-9.
25. Kvale D, Brandtzaeg P, Lovhang D. Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumor necrosis factor-α and gamma interferon. Scand J Immunol 1988; 28:351-7.
26. Witte DP, Welch TR, Beischel LS. Detection and cellular localization of human C4 gene expression in the renal tubular epithelial cell and other extrahepatic epithelial sources. Am J Pathol 1991; 139:717-24.
27. Feucht HE, Jung CM, Gokel MJ et al. Detection of both isotypes of complement C4, C4A and C4B in normal human glomeruli. Kidney Int 1986; 30:932-6.